The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability resulting in approximately three times greater potency than IGF-1, with a significantly longer half-life of about 2030 hours relative to IGF-1s half-life of about 1215 hours
Both affect melanin, but in very different ways
Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus
$45 Grooming Lounge: Grooming Lounge As we get further into fall, gents require a richer, warmer scent that'll jibe perfectly with flannel shirts, leaf raking and power napping
It does not provide medical advice, diagnosis, or treatment, and it makes no therapeutic claims about BPC-157